Literature DB >> 11005940

What is the required reperfusion period for assessment of myocardial infarct size using triphenyltetrazolium chloride staining in the rat?

E R Schwarz1, Y Somoano, S L Hale, R A Kloner.   

Abstract

Measurements of infarct size by use of tripenyltetrazoliumchloride (TTC) is a widely accepted method used to delineate the extent of myocardial necrosis following coronary occlusion and reperfusion in various animal experiments. There is controversy, however, regarding the optimal reperfusion time for estimating the maximally infarcted area by TTC staining in the rat. We tested six different reperfusion times following 90 minutes of regional myocardial ischemia. Group 1 had 5 minutes of reperfusion (n=6), group 2 had 30 minutes of reperfusion (n=6), group 3 had 1 hour of reperfusion (n=6), group 4 had 2 hours of reperfusion (n=6), group 5 had 3 hours of reperfusion (n=6), group 6 had 4.5 hours of reperfusion (n=6). Risk areas, measured by the use of blue dye, were similar among the 6 study groups. Infarct size as a percent of risk area was 57+/-11% in group 1, 74+/-7% in group 2, 61+/-9% in group 3, 71+/-5% in group 4, 70+/-5% in group 5, and 64+/-9% in group 6 (x+/-standard error [SE]). There was no significant difference in infarct size between the groups. However, prior to 60 minutes of reperfusion, patches of pink and white areas were observed within the risk regions, indicating a more difficult assessment of proper delineation of outer regions of necrotic tissue. For acute assessment of infarct size, reperfusion for 60 minutes or more is optimal because the infarct does appear homogeneous at that time and does not become larger with longer reperfusion periods.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11005940     DOI: 10.1023/a:1018770711705

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  22 in total

1.  Differences in reperfusion length following 30 minutes of ischemia in the rabbit influence infarct size, as measured by triphenyltetrazolium chloride staining.

Authors:  Y Birnbaum; S L Hale; R A Kloner
Journal:  J Mol Cell Cardiol       Date:  1997-02       Impact factor: 5.000

2.  An irreversible A1-selective adenosine agonist preconditions rabbit heart.

Authors:  G S Liu; K A Jacobson; J M Downey
Journal:  Can J Cardiol       Date:  1996-05       Impact factor: 5.223

3.  Preconditioning against infarction in the rat heart does not involve a pertussis toxin sensitive G protein.

Authors:  Y Liu; J M Downey
Journal:  Cardiovasc Res       Date:  1993-04       Impact factor: 10.787

4.  Triphenyltetrazolium staining of irreversible ischemic injury following coronary artery occlusion in rats.

Authors:  M T Vivaldi; R A Kloner; F J Schoen
Journal:  Am J Pathol       Date:  1985-12       Impact factor: 4.307

5.  Effect of two perfluorocarbon emulsions on reperfusion injury after coronary artery occlusion in rabbits.

Authors:  S L Hale; H Hammerman; R A Kloner
Journal:  Basic Res Cardiol       Date:  1995 Sep-Oct       Impact factor: 17.165

6.  Cardioprotective effects of ischaemic preconditioning are not mediated by prostanoids.

Authors:  Y Li; R A Kloner
Journal:  Cardiovasc Res       Date:  1992-03       Impact factor: 10.787

7.  Effects of R56865, an Na(+)- and Ca(2+)-overload inhibitor, on myocardial injury in ischemic, reperfused porcine hearts.

Authors:  H H Klein; S Pich; S Lindert-Heimberg; B Maisch; K Nebendahl
Journal:  J Cardiovasc Pharmacol       Date:  1995-01       Impact factor: 3.105

8.  Ischemic preconditioning protects against infarction in rat heart.

Authors:  Y Liu; J M Downey
Journal:  Am J Physiol       Date:  1992-10

9.  Endothelin ETA receptor antagonist reduces myocardial infarction induced by coronary artery occlusion and reperfusion in the rat.

Authors:  J Y Lee; R B Warner; A L Adler; T J Opgenorth
Journal:  Pharmacology       Date:  1994-11       Impact factor: 2.547

10.  Protection of reperfused ischemic pig myocardium by nexopamil, a new combined Ca2+ and serotonin antagonist.

Authors:  T Hohlfeld; M Braun; H Strobach; K Schrör
Journal:  J Cardiovasc Pharmacol       Date:  1994-06       Impact factor: 3.105

View more
  17 in total

Review 1.  Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection.

Authors:  Hans Erik Bøtker; Derek Hausenloy; Ioanna Andreadou; Salvatore Antonucci; Kerstin Boengler; Sean M Davidson; Soni Deshwal; Yvan Devaux; Fabio Di Lisa; Moises Di Sante; Panagiotis Efentakis; Saveria Femminò; David García-Dorado; Zoltán Giricz; Borja Ibanez; Efstathios Iliodromitis; Nina Kaludercic; Petra Kleinbongard; Markus Neuhäuser; Michel Ovize; Pasquale Pagliaro; Michael Rahbek-Schmidt; Marisol Ruiz-Meana; Klaus-Dieter Schlüter; Rainer Schulz; Andreas Skyschally; Catherine Wilder; Derek M Yellon; Peter Ferdinandy; Gerd Heusch
Journal:  Basic Res Cardiol       Date:  2018-08-17       Impact factor: 17.165

2.  Combination of necroptosis and apoptosis inhibition enhances cardioprotection against myocardial ischemia-reperfusion injury.

Authors:  Shizuka Koshinuma; Masami Miyamae; Kazuhiro Kaneda; Junichiro Kotani; Vincent M Figueredo
Journal:  J Anesth       Date:  2013-10-11       Impact factor: 2.078

3.  In vivo visualization and ex vivo quantification of experimental myocardial infarction by indocyanine green fluorescence imaging.

Authors:  Dmitry Sonin; Garry Papayan; Evgeniia Pochkaeva; Svetlana Chefu; Sarkis Minasian; Dmitry Kurapeev; Jarle Vaage; Nickolay Petrishchev; Michael Galagudza
Journal:  Biomed Opt Express       Date:  2016-12-08       Impact factor: 3.732

4.  Ischemic postconditioning does not provide cardioprotection from long-term ischemic injury in isolated male or female rat hearts.

Authors:  Daniel S Lee; Gregory E Steinbaugh; Ricardo Quarrie; Fuchun Yang; M A Hassan Talukder; Jay L Zweier; Juan A Crestanello
Journal:  J Surg Res       Date:  2010-09-26       Impact factor: 2.192

5.  Inhalation of NO during myocardial ischemia reduces infarct size and improves cardiac function.

Authors:  Nils Neye; Fabian Enigk; Sruti Shiva; Helmut Habazettl; Nikolaus Plesnila; Hermann Kuppe; Mark T Gladwin; Wolfgang M Kuebler
Journal:  Intensive Care Med       Date:  2012-06-01       Impact factor: 17.440

6.  Dityrosine as a marker of acute myocardial infarction? Experiments with the isolated Langendorff heart.

Authors:  F Mayer; M Falk; R Huhn; F Behmenburg; S Ritz-Timme
Journal:  Int J Legal Med       Date:  2016-05-16       Impact factor: 2.686

7.  Timing of adenosine 2A receptor stimulation relative to reperfusion has differential effects on infarct size and cardiac function as assessed in mice by MRI.

Authors:  Zequan Yang; Joel Linden; Stuart S Berr; Irving L Kron; George A Beller; Brent A French
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-10       Impact factor: 4.733

8.  Closed-chest small animal model to study myocardial infarction in an MRI environment in real time.

Authors:  Darach O h-Ici; Sarah Jeuthe; Thore Dietrich; Felix Berger; Titus Kuehne; Sebastian Kozerke; Daniel R Messroghli
Journal:  Int J Cardiovasc Imaging       Date:  2014-10-04       Impact factor: 2.357

9.  Neuroprotective antioxidant STAZN protects against myocardial ischemia/reperfusion injury.

Authors:  James J Ley; Ricardo Prado; Jian Qin Wei; Nanette H Bishopric; David A Becker; Myron D Ginsberg
Journal:  Biochem Pharmacol       Date:  2007-09-08       Impact factor: 5.858

10.  Acute hyperglycemia enhances oxidative stress and exacerbates myocardial infarction by activating nicotinamide adenine dinucleotide phosphate oxidase during reperfusion.

Authors:  Zequan Yang; Victor E Laubach; Brent A French; Irving L Kron
Journal:  J Thorac Cardiovasc Surg       Date:  2009-01-18       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.